Orchestra BioMed Holdings, Inc. Ordinary Shares

Go to Orchestra BioMed Holdings, Inc. Ordinary Shares Website

$2.68

0.00 (0.00%)
Live
Previous Close

$2.68

Day Range

$0 - $0

Previous Day Range

$2.52 - $2.71

Market Cap

$93.5 million USD

Day Vol.

0

Previous Day Vol.

580304

Currency

USD

Primary Exchange

Nasdaq

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medic...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Orchestra BioMed's AVIM therapy has received FDA Breakthrough Device Designation for treating uncontrolled hypertension in patients with increased cardiovascular risk, regardless of pacemaker indication. The company is currently enrolling the BACKBEAT global pivotal study to further evaluate the safety and efficacy of AVIM therapy.

Related tickers: OBIO, MDT.

Read Full Article

Orchestra BioMed presented data at the THT 2025 Conference showing that its AVIM therapy significantly improved echocardiographic markers of diastolic dysfunction, an important component in the development of heart failure, in hypertensive patients.

Related tickers: OBIO, MDT, TRUMY.

Read Full Article
Trending Tickers

Please sign in to view